Lv1
30 积分 2024-10-19 加入
Survivin mediates resistance to antiandrogen therapy in prostate cancer
27天前
已完结
Targeting persistent androgen receptor signaling in castration-resistant prostate cancer
27天前
已完结
Survivin mediates resistance to antiandrogen therapy in prostate cancer
2个月前
已完结
Survivin (BIRC5): Implications in cancer therapy
3个月前
已完结
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy
3个月前
已完结
KIF15-Mediated Stabilization of AR and AR-V7 Contributes to Enzalutamide Resistance in Prostate Cancer
4个月前
已完结
Un-methylation of NUDT21 represses docosahexaenoic acid biosynthesis contributing to enzalutamide resistance in prostate cancer
5个月前
已完结
Targeting the Metabolic Enzyme PGAM2 Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting BCL2 Signaling
5个月前
已完结
Un-methylation of NUDT21 represses docosahexaenoic acid biosynthesis contributing to enzalutamide resistance in prostate cancer
5个月前
已完结
SLC4A4 is a novel driver of enzalutamide resistance in prostate cancer
5个月前
已完结
皖公网安备34019202002308
